First Header Logo Second Header Logo

Connection

Robert Hampson to Receptors, Cannabinoid

This is a "connection" page, showing publications Robert Hampson has written about Receptors, Cannabinoid.
Connection Strength

0.278
  1. Howlett AC, Reggio PH, Childers SR, Hampson RE, Ulloa NM, Deutsch DG. Endocannabinoid tone versus constitutive activity of cannabinoid receptors. Br J Pharmacol. 2011 Aug; 163(7):1329-43.
    View in: PubMed
    Score: 0.098
  2. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology. 2004; 47 Suppl 1:345-58.
    View in: PubMed
    Score: 0.058
  3. Hampson RE, Zhuang SY, Weiner JL, Deadwyler SA. Functional significance of cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the hippocampus. J Neurophysiol. 2003 Jul; 90(1):55-64.
    View in: PubMed
    Score: 0.055
  4. Hampson RE, Simeral JD, Kelly EJ, Deadwyler SA. Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons. Hippocampus. 2003; 13(5):543-56.
    View in: PubMed
    Score: 0.054
  5. Grigorenko E, Kittler J, Clayton C, Wallace D, Zhuang S, Bridges D, Bundey S, Boon A, Pagget C, Hayashizaki S, Lowe G, Hampson R, Deadwyler S. Assessment of cannabinoid induced gene changes: tolerance and neuroprotection. Chem Phys Lipids. 2002 Dec 31; 121(1-2):257-66.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.